3.05 USD
▲+0.07+2.35%
盘后 3.01 0.00%
2026-11-20
市值
$112.69M
市盈率
—
EPS
-4.64
股息率
—
52 周区间
2.40 – 14.98
成交量
11.45K
Beta
1.64
目标价
17.50
52W 低 2.4052W 高 14.98
价格走势
公司简介
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.